In a filing, Disc Medicine Inc revealed its Director Bitterman Kevin unloaded Company’s shares for reported $0.14 million on Aug 22 ’25. In the deal valued at $61.03 per share,2,287 shares were sold. As a result of this transaction, Bitterman Kevin now holds 590,621 shares worth roughly $35.23 million.
Then, Atlas Venture Opportunity Fund bought 2,287 shares, generating $136,648 in total proceeds.
Before that, Atlas Venture Fund X, L.P. bought 4,080 shares. Disc Medicine Inc shares valued at $243,780 were divested by the Shareholder at a price of $59.75 per share.
Truist initiated its Disc Medicine Inc [IRON] rating to a Buy in a research note published on July 21, 2025; the price target was $86. TD Cowen started covering the stock on February 27, 2025. It rated IRON as “a Buy”.
Price Performance Review of IRON
On Friday, Disc Medicine Inc [NASDAQ:IRON] saw its stock fall -0.03% to $59.65. Over the last five days, the stock has lost -1.17%. Disc Medicine Inc shares have risen nearly 20.62% since the year began. Nevertheless, the stocks have fallen -5.92% over the past one year. While a 52-week high of $68.73 was reached on 01/02/25, a 52-week low of $30.82 was recorded on 04/09/25.
Levels Of Support And Resistance For IRON Stock
The 24-hour chart illustrates a support level at 58.96, which if violated will result in even more drops to 58.28. On the upside, there is a resistance level at 60.50. A further resistance level may holdings at 61.36.
How much short interest is there in Disc Medicine Inc?
A steep rise in short interest was recorded in Disc Medicine Inc stocks on 2025-08-15, dropping by -0.4 million shares to a total of 2.43 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 2.83 million shares. There was a decline of -16.43%, which implies that there is a negative sentiment for the stock.
